Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-03143-8
Abstract: Cyclin D1, a G1-S phase regulator, is upregulated in parathyroid adenomas. Since cyclin-dependent kinase (CDK) inhibitors, CDKN2A and CDKN2B, and RASSF1A (Ras-association domain family 1, isoform A) are involved in G1-S phase arrest and act… read more here.
Keywords: parathyroid adenomas; cdkn2b rassf1a; cdkn2a cdkn2b; promoter ... See more keywords
9p21.3 Microdeletion involving CDKN2A/2B in a young patient with multiple primary cancers and review of the literature
Sign Up to like & getrecommendations! Published in 2022 at "Cold Spring Harbor Molecular Case Studies"
DOI: 10.1101/mcs.a006164
Abstract: Germline pathogenic variants in CDKN2A predispose to various cancers, including melanoma, pancreatic cancer, and neural system tumors, whereas CDKN2B variants are associated with renal cell carcinoma. A few case reports have described heterozygous germline deletions… read more here.
Keywords: involving cdkn2a; 9p21 microdeletion; microdeletion involving; primary cancers ... See more keywords